JPRN-UMIN000006540已完成2 期
Safety and efficacy of reduced-intensity myeloablative conditioning regimen with fludarabine and intravenous busulfan for hematological malignancies - Safety and efficacy of reduced-intensity myeloablative conditioning regimen with fludarabine and intravenous busulfan for hematological malignancies
niversity of Tsukuba, Department of Hematology0 个研究点目标入组 10 人开始时间: 2011年10月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who are considered as inappropriate to register by attending physicians
研究者
相似试验
招募中
不适用
Safety and efficacy of reduced intensity myeloablative conditioning regimen with fludarabine, cytarabine arabinoside, and cyclophosphamide for hematological malignanciesAcute myeloid leukemia(AML), Myelodysplastic syndrome(MDS), Acute lymphoblastic leukemia(ALL), Malignant lymphoma(ML), chronic myeloid leukemia(CML)JPRN-UMIN000007281Gifu University Hospital36
招募中
3 期
Comparison of conditioning regimens before Hematopoietic Cell Transplantation in patients with Acute Leukemia.Condition 1: Acute Myeloblastic leukemia. Condition 2: Myelodysplastic Syndromes. Condition 3: Acute Lymphoblastic Leukemia.Myelodysplastic syndromesAcute lymphoblastic leukemia [ALL]C92.0C91.0Acute myeloblastic leukemiaIRCT20140818018842N25Tehran University of Medical Sciences84
招募中
2 期
Haplo-RIC in KakogawaLymphoma, leukemia, hematological malignancy018 019 020Hematological malignancyJPRN-jRCTs051180119Okamura Atsuo23
招募中
2 期
Haplo-MAC in KakogawaLymphoma, leukemia, hematological malignancy018 019 020Hematological malignancyJPRN-jRCTs051180118Okamura Atsuo25
尚未招募
不适用
To look for any improvement or decline of a patients status after undergoing surgical removal of thymus by the use of instruments designed to be used through small incisions made on chest.CTRI/2020/06/025612All India Institute of Medical Sciences New Delhi